MST1 and sarcoma: Studies show that promoter methylation of Lats1 and Lats2 is common in schwannomas (17% and 30%, respectively) (49), while promoter methylation of Mst1 and Mst2 has been detected in 37% and 17% of sarcomas, respectively (50).